BIIB vs POST · P/E 21, rev $9.89B vs P/E 15, rev $8.16B
Biogen Inc (BIIB) versus Post Holdings Inc (POST) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Post Holdings Inc (POST) is a packaged foods company listed on NYSE.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported POST revenue for 2025-09-30 was $8.16B. Net income was $335.8M. Revenue was up 3.0% from 2024-09-30 to 2025-09-30. POST currently screens at market cap $4.03B and trailing P/E 14.9.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. POST currently screens at market cap $4.03B and trailing P/E 14.9.
Not investment advice. Open the BIIB and POST stock pages for the full models.
Not investment advice.